SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cadence Pharmaceuticals, Inc. – CADX

[PR Newswire] – NEW YORK, Feb. 11, 2014 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cadence Pharmaceuticals, Inc. (Cadence or the Company) (NasdaqGS: CADX) (ISIN: … more

View todays social media effects on CADX

View the latest stocks trending across Twitter. Click to view dashboard

See who Cadence is hiring next, click here to view